Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2018 / Jan / Innovation Versus Exnovation
Regulation and standards

Innovation Versus Exnovation

Sometimes, we need to go backwards to go forwards in medicine

By Roisin McGuigan 01/18/2018 1 min read

Share

Innovation drives translational science forwards – but what happens after an innovation has been adopted? Sometimes, advancing medical practice means taking note of new evidence and moving in the opposite direction, according to Kimon Bekelis, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, New Hampshire, USA – and first author of a recent study on the importance of de-adoption – also known as exnovation (1). “The process by which innovations enter everyday use has been studied extensively in many disciplines. But the process by which physicians scale back the use of medical practice has received much less attention”, says Bekelis.

Understanding the process of de-adoption – why medical practices fall out of favor – is important when it comes to ensuring that low-value treatments, such as those that have little effect or those that are prohibitively expensive, are reduced in everyday practice, explains Bekelis. Using carotid revascularization – a surgical procedure that has become controversial (2) – as an example, Bekelis and his colleagues looked into the factors that caused a decline in its use. They found that more experienced surgeons were likely to scale back their use of the procedure more quickly – but, on the other hand, surgeons who used the procedure more often were more likely to keep using it. “Reliance on some procedures for financial reasons might deter physicians and organizations from integrating new evidence into clinical practice,” adds Bekelis. Next, the authors plan to find out whether their findings can be applied to other procedures and settings – and they believe that more should be done to ensure that interventions that are not supported by strong evidence are more quickly scaled back in the clinic. “Specialty societies should more aggressively disseminate practice guidelines, and national registries should aid in quality control and benchmarking,” says Bekelis.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. K Bekelis et al., “De-adoption and exnovation in the use of carotid revascularization: retrospective cohort study”, BMJ, 359, j4695 (2017). PMID: 29074624. EA Halm et al., “Has evidence changed practice? Appropriateness of carotid endarterectomy after the clinical trials”, Neurology, 68, 187–194 (2007). PMID: 17224571.

About the Author(s)

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as an Associate Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

More Articles by Roisin McGuigan

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Microbiology and climate change: Building a sustainable future together
Regulation and standards
Microbiology and climate change: Building a sustainable future together

January 27, 2022

1 min read

Playing Chicken With Chicken
Regulation and standards
Playing Chicken With Chicken

October 21, 2016

1 min read

Why is antibiotic resistance in Campylobacter species on the rise – and how can we combat it?

A Pig In a Poke
Regulation and standards
A Pig In a Poke

October 21, 2016

1 min read

When importing livestock for food or breeding, European countries may inadvertently open their borders to superbugs as well

Sneaky Superbugs
Regulation and standards
Sneaky Superbugs

October 21, 2016

1 min read

Norway’s strict LA-MRSA transmission measures prevent the import of almost all live pigs – but the bacteria have found a new way in

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.